Found: 31
Select item for more details and to access through your institution.
Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E549, doi. 10.1002/ajh.24804
- By:
- Publication type:
- Article
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 8, p. E103, doi. 10.1002/ajh.23735
- By:
- Publication type:
- Article
Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 5, p. 487, doi. 10.1002/ajh.23663
- By:
- Publication type:
- Article
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A phase I study.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 9, p. 796, doi. 10.1002/ajh.22092
- By:
- Publication type:
- Article
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 11, p. 733, doi. 10.1002/ajh.21545
- By:
- Publication type:
- Article
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 9, p. 560, doi. 10.1002/ajh.21482
- By:
- Publication type:
- Article
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 542, doi. 10.1093/cid/ciae291
- By:
- Publication type:
- Article
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-02858-0
- By:
- Publication type:
- Article
Whole-Genome Sequencing and Acute Promyelocytic Leukemia.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion Oncogene.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Silybum marianum (milk thistle) in the management and prevention of hepatotoxicity in a patient undergoing reinduction therapy for acute myelogenous leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2012, v. 18, n. 3, p. 360, doi. 10.1177/1078155212438252
- By:
- Publication type:
- Article
Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 1, p. n/a, doi. 10.1111/tid.12629
- By:
- Publication type:
- Article
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clonal Architecture of Secondary Acute Myeloid Leukemia Defined by Single-Cell Sequencing.
- Published in:
- PLoS Genetics, 2014, v. 10, n. 7, p. 1, doi. 10.1371/journal.pgen.1004462
- By:
- Publication type:
- Article
Pathologic, Cytogenetic and Molecular Assessment of Acute Promyelocytic Leukemia Patients Treated with Arsenic Trioxide (As<sub>2</sub>O<sub>3</sub>).
- Published in:
- Modern Pathology, 2000, v. 13, n. 9, p. 954, doi. 10.1038/modpathol.3880174
- By:
- Publication type:
- Article
Comparative Evaluation of Single Fixed Dosing and Weight-Based Dosing of Rasburicase for Tumor Lysis Syndrome.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 3, p. 295, doi. 10.1002/phar.1198
- By:
- Publication type:
- Article
Use of Cytomegalovirus Intravenous Immune Globulin for the Adjunctive Treatment of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients.
- Published in:
- Pharmacotherapy, 2010, v. 30, n. 6, p. 554, doi. 10.1592/phco.30.6.554
- By:
- Publication type:
- Article
Assessment of an Alternative Meropenem Dosing Strategy Compared with Imipenem-Cilastatin or Traditional Meropenem Dosing After Cefepime Failure or Intolerance in Adults with Neutropenic Fever.
- Published in:
- Pharmacotherapy, 2009, v. 29, n. 8, p. 914, doi. 10.1592/phco.29.8.914
- By:
- Publication type:
- Article
The effect of donor type on outcomes in adults with acute myeloid leukemia after reduced‐intensity hematopoietic peripheral blood cell transplant – a retrospective study.
- Published in:
- Transplant International, 2020, v. 33, n. 9, p. 1089, doi. 10.1111/tri.13659
- By:
- Publication type:
- Article
Ruxolitinib for steroid‐refractory acute graft‐versus‐host disease.
- Published in:
- Transplant International, 2020, v. 33, n. 2, p. 244, doi. 10.1111/tri.13560
- By:
- Publication type:
- Article
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2814, doi. 10.1002/cam4.1231
- By:
- Publication type:
- Article
Exome analysis of treatment‐related AML after APL suggests secondary evolution.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.
- Published in:
- Nature, 2015, v. 518, n. 7540, p. 552, doi. 10.1038/nature13968
- By:
- Publication type:
- Article
Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 1, p. 90, doi. 10.1002/cncr.27617
- By:
- Publication type:
- Article
Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all- trans retinoic acid in relapsed/refractory AML.
- Published in:
- International Journal of Hematology, 2014, v. 99, n. 3, p. 272, doi. 10.1007/s12185-014-1503-4
- By:
- Publication type:
- Article
Bone Marrow Biopsy Needle Type Affects Core Biopsy Specimen Length and Quality and Aspirate Hemodilution.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Pharmacokinetic Study of Infusional Valspodar.
- Published in:
- Journal of Clinical Pharmacology, 2002, v. 42, n. 4, p. 412, doi. 10.1177/0091270002424007
- By:
- Publication type:
- Article
Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.
- Published in:
- Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 75, doi. 10.1186/1756-8722-5-75
- By:
- Publication type:
- Article